Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.


TSX:BCT - Post by User

Bullboard Posts
Post by ValueHunter92on Apr 04, 2016 9:03am
130 Views
Post# 24726889

Regarding positive outcomes and false perception

Regarding positive outcomes and false perception

Hi Board,

As previously mentionned, I've been working 20years + in the pharmaceutical and medical industry, and I rarely seens some positive results like Bria did release, this is why I purchased shares althought.

Regarding the conference at the 18 april, we don't give a damn about what happens there, the points is major players already acknowledges the mains idea in the results, and they are highly likely to takeover the company in the nearest terms, specially before they do any more positive result that will take the company valuation 200-400%. They won't buy 10-20% to get the PPS to 30 or 40 cent, they will buy 51% or more, to benefit and be granted of the pattent.

Finally, I confirmed with ex-FDA employes regarding the viability of this treaments sinces the FDA gave right to try it on others cancers, and I've been confirmed that it is an incredibly positive sign regarding their BriaVax treaments. Thus, I beleive we are looking for a 60-70cent takeover, minimally, maybe more if their is a betting competition between majors.

JMHO, but don't wait for the conference, just waits fews weeks or maybe even days, and a majors will come and bid and this company will be taken private

 

Regards

Dr Shreiber.

PhD Pharmaco-Biologist

Bullboard Posts